Save18%
Original price$ 94.95
Current price$ 77.95
SKU00002-7597-01
Medical Professional License Required to Unlock Account(Note: We don’t Fill Personal Prescriptions)How to Order:
✔Send an email request to: [email protected]
You will receive instructions on how to create an account along with Rx Ordering Details.
Zyprexa Olanzapine for Injection 10 mg is a prescription medication used to treat acute agitation in patients with schizophrenia and bipolar disorder. It contains the active ingredient olanzapine, which belongs to a class of medications called atypical antipsychotics. This medication works by blocking certain receptors in the brain to regulate the levels of chemicals involved in mood and behavior. It is administered as an injection into a muscle by a healthcare professional and may be used for short-term treatment in a hospital setting. It is not a cure for schizophrenia or bipolar disorder but can help manage symptoms.
Mechanism of Action
Zyprexa Olanzapine is an antipsychotic medication that works by blocking the activity of dopamine and serotonin receptors in the brain. Dopamine and serotonin are neurotransmitters that regulate mood, behavior, and cognition.
By blocking these receptors, Zyprexa Olanzapine helps to balance the levels of these neurotransmitters in the brain, which can improve symptoms of psychosis, such as delusions, hallucinations, and disorganized thinking.
Additionally, Zyprexa Olanzapine also blocks the activity of other neurotransmitters, such as histamine and norepinephrine, which can contribute to the sedative and anti-anxiety effects of the medication.
Overall, the mechanism of action for Zyprexa Olanzapine is to modulate the activity of various neurotransmitters in the brain, leading to a reduction in psychotic symptoms and improvements in behavior and mood.
Zyprexa Olanzapine for Injection 10mg Vial is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). It may also be used in combination with other medication to treat depression.
Olanzapine is an antipsychotic medication that affects chemicals in the brain. Olanzapine is used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression) in adults and children who are at least 13 years old.
Brand: LillySize: 10mgNDC: 00002-7597-01UPC: 00002-7597-01
Buy Zyprexa Olanzapine for Injection 10mg Vial online at Mountainside Medical Equipment.
IRE PharmacyWe have received approval from FDA to deliver This product to US and other countries. This product is approved for use in adults and children who are diagnosed with acute agitation (e.g., agitation due to agitation due to something going on in their home), schizophrenia, bipolar disorder, or depression. It is not approved for use in children and adolescents.
Reviews have received from individuals who have experienced positive changes in psychotic symptoms with Zyprexa Olanzapine. These reviews have praised Olanzapine for its relief of psychotic conditions (such as schizophrenia) that are commonly associated with olanzapine. However, it is important to note that individual responses to medication may vary and not the full benefits. Some individuals may experience positive changes in symptoms while taking Zyprexa Olanzapine, including:
Reviews have found Zyprexa Olanzapine to be an effective medication in the treatment of acute agitation (e.g., agitation due to agitation due to something going on in a home), schizophrenia, bipolar disorder, or depression.
PITTSBURGH: For the first time, the U. S. Food and Drug Administration (FDA) announced it has approved Teva Pharmaceuticals LP’s Abbreviated New Drug Application for Teva Pharmaceuticals LP’s generic equivalent of Zyprexa® (olanzapine). The approval is the first for the new drug formulation of Zyprexa® for treatment of schizophrenia. Teva Pharmaceuticals LP’s Abbreviated New Drug Application for Teva Pharmaceuticals LP’s generic equivalent of Zyprexa® is approved in the U. and Europe for treatment of schizophrenia and acute manic episodes in adults.
PITTSBURGH, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals LP (“ Teva” or the “Company”) (“Teva”) (“the “Company”) (LLC) (1) today announced financial results for the first quarter ended December 31, 2021, and for the year ended December 31, 2020, for the first nine months of 2020 and for the year ended December 31, 2020, for the first nine months of 2021. The Company recognized the Company’s financial results for the first nine months of 2020 and for the first nine months of 2021. For the full year ended December 31, 2020, Teva adjusted its guidance for 2020 at its earnings per share and adjusted for 2020 earnings per share of $6.15 per diluted share and 2021 earnings per share of $5.24 per diluted share, as reflected in the diluted EPS guidance. The Company also recognized its guidance for the full year ended December 31, 2020, at its earnings per share and adjusted for 2020 earnings per share of $3.25 per diluted share, as reflected in the diluted EPS guidance. Additionally, the Company recognized its guidance for the full year ended December 31, 2020, at its earnings per share and adjusted for 2020 earnings per share of $6.15 per diluted share, as reflected in the diluted EPS guidance. These results are consistent with the results in the first nine months of 2020 and for the first nine months of 2021, in which Teva adjusted its guidance for 2020 at its earnings per share and adjusted for 2020 earnings per share of $5.24 per diluted share, as reflected in the diluted EPS guidance. Teva also recognized that it continued to have strong positive operating results in the first nine months of 2021 and continued to have strong negative operating results in the first nine months of 2021, as reflected in the diluted earnings guidance.
“Today’s results are a positive reflection of Teva’s continued strong performance and the strong financial guidance we have received for the first nine months of 2020 and for the first nine months of 2021. These results further solidify our continued strong financial commitment to our shareholders and our continued commitment to our clients,” said Chris Herrington, Chief Executive Officer of Teva. “Teva has consistently demonstrated that we continue to continue to deliver high-quality, reliable financial results to our shareholders, and we are excited to continue to work closely with our peers and our stakeholders to achieve our target of delivering a more balanced and positive financial outlook for our clients.”
“We are very pleased with the results of our first nine months of 2020 and for the first nine months of 2021. We are also excited to see the positive financial results from our fourth quarter of 2021, which have been consistently positive and continue to deliver strong financial performance,” Herrington added.
About Teva Pharmaceuticals LP
Teva Pharmaceuticals LP (“Teva”) is a global, pharmaceutical company focused on bringing innovative medicines to patients across the globe. The Company is one of the world’s leading pharmaceutical companies with a presence in more than 150 countries and territories and is in over 80% of the world’s prescription medicines sales. Teva’s primary business is in the specialty areas of oncology, gastroenterology, oncology drugs, and respiratory diseases, as well as a number of other specialty and manufacturing businesses. With a global presence spanning more than 100 countries, including the U. S., Canada, Japan, India, China, Brazil, South Korea, Turkey, Russia, South Africa, Ukraine and more than 100 member nations, Teva has strong global presence and a strong financial position. Teva’s primary focus is on new therapies and innovative medicines, which are expected to be launched in the coming years.
Olanzapine, commonly known by its trade name Zyprexa, is a medication approved by the US Food and Drug Administration for the treatment of schizophrenia, bipolar disorder, and other neurological disorders. It is available in various forms, including tablets, orally disintegrating wafers, and intramuscular injections[4].
The global olanzapine market has demonstrated steady growth in recent years. As of 2023, the market size was valued at approximately $2.55 billion, and it is expected to grow to $2.62 billion in 2024 at a compound annual growth rate (CAGR) of 3.1%. By 2028, the market is projected to reach $2.93 billion with a CAGR of 2.8%[2].
Another report indicates that the market size was valued at $3.34 billion in 2023 and is expected to grow at a CAGR of 2.5% from 2024 to 2030, reaching nearly $3.97 billion by 2030[4].
The global olanzapine market is segmented into brand name Zyprexa and generic olanzapine marketSEZOAB common Sezapine generic common Sezapine brand Sezapine brand 0.625mL TabletCommon: 0.625, 0.88, and 0.88, respectively. Common Sezapine brand is Abilify. Common generic Sezapine brand is 1MG. Common dosage form 0.625mL/1 tablet is as follows:
The prices of olanzapine 0.625mL and olanzapine 1 1 0.88 in North America are approximately $2.63 and $1.12, respectively, while the prices of generic olanzapine 0.88 and generic sezapine 1 1 0.87 in Europe are approximately $1.52 and $0.97, and prices of common sezapine 1 0.625 and generic sezapine 0.88 in Canada are approximately $0.55 and $0.95, respectively[5].
Based on currently marketed prices, the market potential of olanzapine 0.625 or olanzapine 1 1 0.87 in the United States, Canada, France, United Kingdom, Italy, and Australia is estimated to be approximately $2.63 to $3.1 billion by 2030, with a CAGR of 2.8%[2].
Zyprexa works by blocking a chemical called dopamine in the brain. This drug is used to treat schizophrenia and bipolar disorder. Unlike some other medicines used to treat these conditions, Zyprexa has shown great improvement in managing symptoms.
Zyprexa is a drug made by Eli Lilly and Co., a company that manufactures and sells various medicines for schizophrenia and bipolar disorder. Zyprexa can help people suffering from these conditions by acting on the brain's neurotransmitters and reducing the symptoms of these conditions.
For schizophrenia and bipolar disorder, Zyprexa works by blocking the activity of dopamine in the brain. Dopamine is a neurotransmitter that plays a role in mood regulation and the functioning of cells in the brain. When the body becomes hyperactive, its activity increases. This is how Zyprexa treats these conditions.
In bipolar disorder, Zyprexa helps to treat symptoms of mania or depression. It also helps in managing the symptoms of bipolar disorder, although the exact mechanisms of action are still unknown.
The main side effects of Zyprexa include insomnia, nervousness, dizziness, irritability, dry mouth, difficulty sleeping, and more.
It is important to note that Zyprexa can cause serious side effects in some individuals. If you experience any unusual symptoms while taking this medication, contact your healthcare provider immediately.
When taking Zyprexa, it is important to follow the dosage recommendations. For example, taking Zyprexa at least 2 hours before or 2 hours after a meal can help prevent the symptoms of schizophrenia.
In addition, taking Zyprexa at least 4 hours before or 6 hours after eating or drinking alcohol can help prevent the symptoms of depression. This medication can also help with anxiety symptoms such as restlessness, excessive sweating, muscle tremors, irritability, and anxiety.
It is also important to note that Zyprexa can be taken with or without food.
Zyprexa should be taken at least 30 minutes before or 2 minutes after eating or drinking alcohol. Taking Zyprexa with food may also help alleviate symptoms of anxiety and depression. This medication should be taken with a full glass of water.
It is important to note that Zyprexa can cause sedation. This medication can help with these effects. It is important to continue taking Zyprexa long-term and to avoid excessive alcohol intake.
This medication can help with schizophrenia and bipolar disorder. However, it does not cure these conditions. It does not treat depression or panic disorder.
When taking Zyprexa, it is important to follow the recommended dosage.
It is also important to note that Zyprexa can cause serious side effects in some individuals.
Like any medication, Zyprexa can cause side effects. These side effects are uncommon and can occur but rarely, especially if you have a history of diabetes or cardiovascular disease.
Stade de France Pharmacy